BioCryst Pharmaceuticals (NASDAQ:BCRX): Q4 EPS of $0.35 beats by $0.26. Revenue of $55M (+60.5%)...
Recommended For You
More Trending News
About BCRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BCRX | - | - |
BioCryst Pharmaceuticals, Inc. |
Symbol | Last Price | % Chg |
---|---|---|
BCRX | - | - |
BioCryst Pharmaceuticals, Inc. |